Rare Thyroid Therapeutics is located in Stockholm, Sweden on Teatergatan 3. Rare Thyroid Therapeutics is rated 3 out of 5 in the category pharmaceuticals in Sweden. Rare Thyroid Therapeutics is a privately held pharmaceutical company, developing therapies for rare and neglected thyroid hormone disorders. Our lead product candidate Emcitate® is under development for the treatment of MCT8 deficiency, also called Allan-Herndon-Dudley Syndrome, a rare inborn X-linked disorder caused by a dysfunctional thyroid hormone transporter.
Company size
1-10 employees
Headquarters
Stockholm, Stockholm County